Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
15 studies found for:    weill AND neurologic changes | Open Studies
Show Display Options
Rank Status Study
1 Recruiting Intra-arterial Chemotherapy for Spinal Metastases
Conditions: Spinal Diseases;   Spinal Metastases;   Spinal Tumors
Intervention: Drug: Melphalan (intra-arterial infusion)
2 Recruiting MRI and Diffusion Imaging of Eloquent Brain Areas to Optimize Brain Tumor Resection Planning
Condition: Brain Cancer
Intervention: Procedure: preoperative fMRI. DTI and DSI with tractography
3 Recruiting A Study to Characterize the Cardiac Phenotype of Individuals With Friedreich's Ataxia (CARFA Study)
Condition: Friedreich's Ataxia
Interventions: Procedure: Cardiac magnetic resonance imaging (CMR);   Procedure: Exercise-stress test;   Procedure: Echocardiography (ECHO);   Procedure: Cardiac-related blood studies
4 Not yet recruiting Exploratory Study of Melatonin Induced Sleep Regularization in Severe Brain Injury
Condition: Disorders of Consciousness
Intervention: Dietary Supplement: melatonin
5 Recruiting Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial
Conditions: Acute Ischemic Stroke;   Diabetes;   Hyperglycemia
Interventions: Drug: IV insulin to maintain target glucose concentration of 80-130 mg/dL;   Drug: Standard Care control - sliding scale insulin to keep glucose less than 180 mg/dL
6 Recruiting Venous Sinus Stenting To Treat Intractable Pulsatile Tinnitus Caused By Venous Sinus Stenosis
Conditions: Tinnitus;   Pulsatile Tinnitus;   Venous Sinus Stenosis;   Dural Sinus Stenosis
Intervention: Device: Venous Sinus Stenting
7 Not yet recruiting Statin Neuroprotection and Carotid Endarterectomy: Safety, Feasibility and Outcomes
Conditions: Carotid Artery Stenosis;   Strokes
Interventions: Drug: Statin;   Drug: Atorvastatin;   Other: Placebo
8 Recruiting Study of Urate Elevation in Parkinson's Disease, Phase 3
Condition: Parkinson's Disease
Interventions: Drug: Inosine;   Drug: Placebo
9 Recruiting Intracerebral Hemorrhage Deferoxamine Trial - iDEF Ttrial
Condition: Intracerebral Hemorrhage
Interventions: Drug: Deferoxamine Mesylate;   Drug: Placebo (for Deferoxamine Mesylate)
10 Recruiting 221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Aducanumab (BIIB037);   Drug: Placebo
11 Recruiting Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III
Condition: Intracerebral Hemorrhage
Intervention: Drug: rt-PA
12 Recruiting P2/3 Randomized Study of Toca 511 & Toca FC Versus SOC in Subjects Undergoing Surgery for Recurrent GBM/AA
Conditions: Glioblastoma Multiforme;   Anaplastic Astrocytoma
Interventions: Biological: Toca 511;   Drug: Toca FC;   Drug: Lomustine;   Drug: Temozolomide;   Biological: Bevacizumab
13 Recruiting Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Condition: Cognition Disorders
Interventions: Drug: Solanezumab;   Drug: Placebo
14 Recruiting Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial
Condition: Carotid Stenosis
Interventions: Procedure: Carotid endarterectomy;   Device: Carotid stenting
15 Recruiting Stenting in the Treatment of Aneurysm Trial
Condition: Intracranial Aneurysm
Interventions: Device: endovascular coiling with any type of currently approved coil (first or second generation);   Device: endovascular stenting with or without coiling. The stent may be any of the currently approved stents for intracranial aneurysms.

Study has passed its completion date and status has not been verified in more than two years.